DEXCOM INC — Director's Dealing 2018

Jun 27, 2018

SEC Form 4/A — Form 4/A

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2018-06-01

Reporting Person: FOLETTA MARK G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-01	Common Stock	A	4052	$0.001	Acquired	4052	Direct

Footnotes

F1: The RSU Award was granted on June 1, 2018 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2019 Annual Meeting. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. commom stock upon settlement.